Access to Medicines in Africa

Supporting Access to Medicines and Industrial Development in Africa: Investing in Domestic Pharmaceutical Manufacturing

In cooperation with UNAIDS, the African Union and Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ)

Date: 21 July 2016
Time: 13:00-15:00
Location: Kenyatta International Convention Centre, Green Room

As a follow-up to the World Investment Forum 2014 session on investment in sustainable and universal access to medicines, this event will highlight political commitments and concrete business opportunities for expanding local production of pharmaceutical products in Africa and beyond, in order to promote access to medicines and related health commodities, particularly for scaling up access to HIV and TB testing and treatment. The event thereby seeks to support the new Sustainable Development Goals (SDGs), in particular SDG 3, SDG 9 and SDG 17.

Issues to be addressed

In order to improve the continent’s health security, African leaders have in recent years demonstrated important political commitment to support the local production of pharmaceutical products. One of the biggest challenges currently faced by African local pharmaceutical producers is how to meet requirements related to the quality, safety and efficacy of medicines and good manufacturing practices (GMP). This requires investment in quality upgrading. Access to credit is thus essential but domestic commercial banks are often hesitant to engage in long-term projects. Foreign investment and government support therefore play a major role in the promotion of local production of quality medicines and the transfer of GMP-related technologies and know-how. This event seeks to address the following issues:

  • The role of a coherent policy framework on health, trade, investment and intellectual property to attract foreign investors and promote domestic pharmaceutical production capacity;
  • The identification of concrete business opportunities between local producers and potential investors.

Opening remarks

  • Mr. James Zhan, Director, Division on Investment and Enterprise, UNCTAD


  • Dr. Mukhisa Kituyi, Secretary-General, UNCTAD
  • Mr. Michel Sidibé, Executive Director, UNAIDS (represented by Abdoul Dieng, Chief of Policy Coordination and Programme Communication Office, UNAIDS)
  • Ms. Fatima Acyl, Commissioner for Trade and Industry, African Union Commission
  • Dr. Cleopa Mailu, Minister of Health, Ministry of Health, Kenya

  • Dr. Rob Davies, Minister of Trade and Industry, Department of Trade and Industry, South Africa
  • Dr. Isaac Adewole, Minister of Health, Nigeria (through representation)
  • Mr. Kofi Nsiah-Poku, Vice President, West African Pharmaceutical Manufacturers Association (WAPMA) and CEO, Kinapharma Ltd., Ghana                
  • Mr. Palu Dhanani, Managing Director, Universal Corp. Ltd., Kenya
  • Mr. Dilip Shah, Secretary General, Indian Pharmaceutical Alliance, India
  • Mr. Xiaoyong Wang, Secretary General, China-Africa Business Council, China
  • Mr. Greg Perry, Executive Director, Medicines Patent Pool, Switzerland
  • Ms. Maureen Mackintosh, Professor of Economics, The Open University, United Kingdom


  • Ms. Jantine Jacobi, Country Director Kenya, UNAIDS
  • Ms. Adrienne Klasa, Editor, Financial Times, United Kingdom
  • Ms. Michelle Morin Conrey, Managing Director, Impact Africa Capital, Uganda
  • Mr. Bork Bretthauer, Chair, German Generic Manufacturers Association (Pro Generika), Germany
  • Ms. Anja Kopyra, Senior Policy Officer, Federal Ministry for Economic Cooperation & Development, Germany
  • Mr. Haikuan Lu, Chairman, Deer Jet Medical, China
  • Mr. Sergio Napolitano, Legal Affairs and Trade Director, Medicines for Europe, Belgium
  • Ms. Roslyn Ng’eno, Manager Policy Advocacy, Kenya Investment Authority, Kenya
  • Mr. Fredrick Nzwili, Journalist, Intellectual Property Watch, Switzerland
  • Dr. Mukdavan Prakobvaitayakit, Director, Government Pharmaceutical Organization, Thailand
  • Ms. Godelieve Quisthoudt-Rowohl, MEP, European Parliament, Belgium
  • Mr. Dirk Rabien, Project Manager, Deutsche Gesellschaft für Internationale Zusammenarbeit (GIZ), Germany
  • Mr. S.M. Shafiuzzaman, President, Bangladesh Association of Pharmaceutical Industries, Bangladesh
  • Mr. Alastair West, PMPA Business Plan Coordinator, UNIDO, Austria
  • Ms. Nazha Bennabes Aschenbrenner, former UNCTAD Head of Branch, DIAE


Statement by Sahar Afzal, Dutch United Nations Youth Representative